Colorcon opens Colombia formulation lab

By Staff Reporter

- Last updated on GMT

Colorcon opens Colombia formulation lab

Related tags Active ingredient

Colorcon has opened a formulation laboratory in Colombia to build its presence in the fast growing South American pharmaceutical market.

The facility, in Bogota, houses a formulation lab and a service centre and was designed to meet “internationally recognized certification for the containment and safe handling of Level II and Level IV active pharmaceutical ingredients (APIs)”​ according to Colorcon.

The ability to handle API is important for customers according to regional sales manager Carlos LaCruz, who said: “We can provide specialized support to accelerate development and commercialization of robust, high quality pharmaceutical drug formulations.​”

This was echoed by regional technical manager Plinio Sandoval, who said: “Colorcon has invested in new-instrumented equipment, including high shear granulation, an instrumented press machine, advanced film coating equipment and USP dissolution apparatus.​ 

Access to this advanced technology and analytical tools enables more robust formulation development, provides release profiles and ultimately better prediction for scale-up to manufacturing​.”

The Bogota service centre is Colorcon’s fourth in Latin America. The coating technology and formulation services firm has similar sites in Argentina, Mexico and Brazil. It also operates a sales and distribution centre in Venezuela.

The laboratory is the first new site Colorcon has opened since it set up facility in Beijing's YiZhuang Biomedical Park in China last year​.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more